Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M119,494Revenue $M45,912Net Margin (%)7.6Altman Z-Score2.1
Enterprise Value $M130,817EPS $4.5Operating Margin %9.8Piotroski F-Score6
P/E(ttm)33.2Beneish M-Score-2.5Pre-tax Margin (%)9.8Higher ROA y-yN
Price/Book5.110-y EBITDA Growth Rate %5.7Quick Ratio0.8Cash flow > EarningsY
Price/Sales2.55-y EBITDA Growth Rate %3.3Current Ratio1.2Lower Leverage y-yN
Price/Free Cash Flow27.4y-y EBITDA Growth Rate %-0.9ROA % (ttm)5.2Higher Current Ratio y-yN
Dividend Yield %1.8PEG10.4ROE % (ttm)16.1Less Shares Outstanding y-yY
Payout Ratio %52.0Shares Outstanding M827ROIC % (ttm)10.0Gross Margin Increase y-yY

Gurus Latest Trades with BAYRY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BAYRYKen Fisher 2015-03-31 Add$130.2 - $155.97
($144.95)
$ 144.50-0%Add 0.63%2,509,075
BAYRYKen Fisher 2014-06-30 Add0.6%$126.84 - $144.81
($138.38)
$ 144.504%Add 750.48%2,302,369
BAYRYKen Fisher 2014-03-31 Add0.06%$128.3 - $142.7
($135.49)
$ 144.507%Add 217.05%270,713
BAYRYKen Fisher 2013-06-30 Add0.01%$101 - $112.75
($106.88)
$ 144.5035%Add 34.62%84,456
BAYRYVanguard Health Care Fund 2012-09-30 Reduce-0.03%$68.01 - $88.62
($77.6)
$ 144.5086%Reduce 3.71%2,594,656
BAYRYKen Fisher 2012-09-30 Buy 0.02%$68.01 - $88.62
($77.14)
$ 144.5087%New holding72,838
BAYRYKen Fisher 2012-03-31 Sold Out -0.01%$0.04 - $75.15
($59.98)
$ 144.50141%Sold Out0
BAYRYKen Fisher 2011-09-30 Add$49.73 - $84.17
($66.88)
$ 144.50116%Add 24.27%46,440
BAYRYJohn Keeley 2009-06-30 Sold Out -0.01%$47.66 - $59.35
($52.77)
$ 144.50174%Sold Out0
BAYRYKen Fisher 2009-06-30 Sold Out $47.66 - $59.35
($52.77)
$ 144.50174%Sold Out0
BAYRYJohn Keeley 2009-03-31 Buy 0.01%$43.75 - $59.4
($52.7)
$ 144.50174%New holding6,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BAYRY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BAYRY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about BAYRY :

    Quarterly/Annual Reports about BAYRY:

      News about BAYRY:

      Articles On GuruFocus.com
      Bayer AG Wins Approval On Existing Antibiotic For Plague Treatment May 12 2015 
      Bayer Enters Into Collaboration With Isis For Enhancing Its Drug Portfolio May 07 2015 
      DuPont Eyeing Acquisition To Leverage Its Market Spread Apr 24 2015 
      savings Apr 22 2015 
      Bayer Goes Into Disinvestment Mode Due To Falling Profit Numbers Feb 27 2015 
      Zoetis Will Benefit from Industry Trends Oct 07 2014 
      Baxter Will Remain Diversified and With Competitive Advantages Sep 02 2014 
      Ken Fisher's Top Increaes of the Second Quarter Jul 28 2014 
      We Are Confident About Baxter's Plan to Create Two Separate Health Care Companies Mar 28 2014 
      Mallinckrodt Acquired San Diego Pharma and Much More Mar 21 2014 

      More From Other Websites
      Bayer CropScience at the ISF World Seed Congress 2015 in Kraków: -- Proactive stewardship is... May 27 2015
      Dr. Marijn Dekkers at the Annual Stockholders’ Meeting of Bayer AG: -- Bayer has outstanding... May 27 2015
      Annual Stockholders’ Meeting -- Address by Dr. Marijn Dekkers -- Chairman of the Board of... May 27 2015
      From approx. 10:00 CEST (8:00 UTC): -- Live video broadcast of the speeches given by Werner Wenning,... May 27 2015
      [$$] EU to Revisit Question of Insecticides’ Responsibility for Bee Die-Offs May 26 2015
      Sinocare bids for Bayer's Contour unit - Bloomberg May 20 2015
      Sinocare Said to Enter Bidding for Bayer’s Diabetes Devices Unit May 19 2015
      Bayer at a glance: -- New edition of “Names, Figures, Facts” -- Service line for free booklet May 19 2015
      Boosting innovation capacities through venture capital and strategic collaborations -- Bayer... May 05 2015
      Makrolon® Silent Sound for noise protection barriers -- Transparent noise protection for humans and... May 05 2015
      Achieving customized automotive interiors easily and cost-effectively -- Easy on the eyes -- Bayer... May 05 2015
      GroGenesis Aims to Become Leader in Natural Plant Growth Technologies May 04 2015
      Bayer Licenses ISIS-FXI Rx from Isis Pharmaceuticals to Develop and Commercialize for the Prevention... May 04 2015
      Bayer MaterialScience develops new isocyanate with rapid curing -- Innovative adhesive raw material... Apr 22 2015
      Fewer layers, faster curing -- Cost-effective and flexible coating with polyaspartic coatings -- For... Apr 22 2015
      Bayer MaterialScience and partners optimize polyurethane systems for automotive clearcoats -- Fast... Apr 22 2015
      OTC Markets Group Announces First Quarter 2015 Performance of OTCQX and OTCQB Indexes, OTCM ADR... Apr 16 2015
      Bayer AG downgraded by Morgan Stanley Apr 16 2015
      Bayer to Expand Copanlisib Program by Three New Studies - Analyst Blog Apr 15 2015
      Bayer to early redeem EUR 1.3 billion bond issued in 2005 Apr 15 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      FEEDBACK